Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Growth Rate of the Pelvic Inflammatory Disease (PID) Treatment Market?
In recent times, the market size for the treatment of pelvic inflammatory disease (PID) has seen notable expansion. With a compound annual growth rate (CAGR) of 5.8%, the market is projected to rise from $4.49 billion in 2024 to $4.75 billion in 2025. The historic growth is attributable to factors such as the increasing use of telemedicine, a surge in sexually transmitted infection occurrences, growing awareness about PID, and a rise in healthcare spending.
What Growth Rate Is Forecasted for the Pelvic Inflammatory Disease (PID) Treatment Market by 2029?
Anticipated robust expansion is on the cards for the pelvic inflammatory disease (PID) treatment market in the ensuing years, with a projection to escalate to $5.88 billion by 2029, reflecting a compound annual growth rate (CAGR) of 5.5%. Factors contributing to growth during the forecast period include a surge in sexually transmitted infections, heightened consciousness about the health of female reproductive systems, escalating public knowledge of pelvic inflammatory disease, growing dependence on telehealth facilities, and an upsurge in instances of sexually transmitted infections (STIs). Key trends during the forecast period encompass innovative PID treatment products, enhancements in diagnostic technologies, newly introduced concepts like customized treatment, sophisticated imaging techniques, and technological progression.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21251&type=smp
Which Key Companies Are Shaping the Future of the Pelvic Inflammatory Disease (PID) Treatment Market?
Major companies operating in the pelvic inflammatory disease (PID) treatment market are Pfizer Inc., Bayer AG, Eli Lilly and Company, Otsuka Pharmaceutical Co. Ltd., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Hetero Drugs Ltd., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Dr. Reddy’s Laboratories Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, Lupin Pharmaceuticals Inc., Torrent Pharmaceuticals Ltd., Mankind Pharma Ltd., Mayne Pharma Group Limited, Saphnix Lifesciences, Aristo Pharmaceuticals Pvt. Ltd., Zydus Cadila Healthcare Ltd., Amagen India Life Sciences.
Which Factors Are Driving Demand in the Pelvic Inflammatory Disease (PID) Treatment Industry?
The growth of the pelvic inflammatory disease (PID) treatment market is anticipated to be driven by rising incidences of sexually transmitted infections. Caused by bacteria, viruses, or parasites, these infections predominantly spread via sexual intercourses like vaginal, oral, or anal encounters. The escalation in sexually transmitted infections can be attributed to factors like unprotected sex, risky sexual conduct, inadequate awareness, and delayed diagnosis and treatment. PID treatment plays a crucial role in managing these infections by using antibiotics to eradicate infection-inducing bacteria, preventing possible complications like chronic pelvic pain and infertility and lowers the risk of recurrent infections. As stated in a report by the UK Health Security Agency (UKHSA), a government agency based in the UK, England witnessed 6,008 new HIV diagnoses in 2023, a 51% rise from the 3,975 diagnoses in 2022. Hence, the progressing incidence of sexually transmitted infections is propelling the expansion of the PID treatment market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=21251&type=smp
How Is the Pelvic Inflammatory Disease (PID) Treatment Market Segmented by Several Divisions?
The pelvic inflammatory disease (PID) treatment market covered in this report is segmented –
1) By Treatment Type: Antibiotic Therapy, Surgery, Pain Management, Hormonal Therapy
2) By Route Of Administration: Oral, Intravenous, Intramuscular
3) By End User: Hospitals, Clinics, Homecare
Subsegments:
1) By Antibiotic Therapy: Broad-spectrum Antibiotics, Combination Antibiotic Therapy, Oral Antibiotics, Intravenous Antibiotics
2) By Surgery: Laparoscopy, Hysterectomy, Tubal Surgery
3) By Pain Management: Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Opioid Analgesics, Acetaminophen, Localized Pain Management
4) By Hormonal Therapy: Birth Control Pills, Hormonal Intrauterine Device (IUD), Progesterone Therapy
What are the Emerging Market Trends Driving the Growth of the Pelvic Inflammatory Disease (PID) Treatment Industry?
Key players in the pelvic inflammatory disease (PID) treatment market are channeling their focus on developing innovative formulations like probiotic supplements, aimed at boosting treatment effectiveness, reinstating a healthy balance of vaginal microbiota, and decreasing the frequency of re-infections in PID patients. Probiotic supplements are products containing beneficial live bacteria or yeasts that promote a healthy balance of gut and vaginal microbiota. For instance, Lee Health Domain, a pharmaceutical firm based in India, introduced V-Ferin, a probiotic supplement dedicated to vaginal wellbeing in November 2024. V-Ferin, compounded with Lactobacillus acidophilus, lactoferrin peptide, and cranberry extract, aspires to rejuvenate the natural microbiome and protect against common vaginal infections, such as bacterial vaginosis and yeast infections. Seeing as about 25-30% of women suffer from these ailments which could evolve into PID if left untreated, V-Ferin provides an innovative means to enhance health and prevent potential complications.
Access The Full Report Here:
Which Regions Are Driving Growth in the Pelvic Inflammatory Disease (PID) Treatment Market?
North America was the largest region in the pelvic inflammatory disease (PID) treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pelvic inflammatory disease (PID) treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21251
This Report Delivers Insight On:
1. How big is the pelvic inflammatory disease (pid) treatment market, and how is it changing globally?
2. Who are the major companies in the pelvic inflammatory disease (pid) treatment market, and how are they performing?
3. What are the key opportunities and risks in the pelvic inflammatory disease (pid) treatment market right now?
4. Which products or customer segments are growing the most in the pelvic inflammatory disease (pid) treatment market?
5. What factors are helping or slowing down the growth of the pelvic inflammatory disease (pid) treatment market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
